Petros Pharmaceuticals, Inc. (PTPI)
0.005
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Petros Pharmaceuticals Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2024 | 2.615M |
| September 30, 2024 | 2.902M |
| June 30, 2024 | 3.180M |
| March 31, 2024 | 3.131M |
| September 30, 2023 | 1.752M |
| June 30, 2023 | 2.099M |
| March 31, 2023 | 1.654M |
| December 31, 2022 | 1.740M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.843M |
| June 30, 2022 | 1.607M |
| March 31, 2022 | 1.205M |
| September 30, 2021 | 0.8366M |
| June 30, 2021 | 0.6876M |
| March 31, 2021 | 0.327M |
| September 30, 2020 | 0.3078M |
| June 30, 2020 | 0.271M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Accuray, Inc. | 37.80M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 60.33M |
| ResMed, Inc. | 378.28M |
| Rockwell Medical, Inc. | -- |